Increasing importance of multidrug-resistant serotype 6A streptococcus pneumoniae clones in acute otitis media in Southern Israel

Pediatric Infectious Disease Journal

Volumn 29, Issue 2, 2010, Pages 126-130

  Porat, Nurith ^a   Amit, Uri ^a   Givon Lavi, Noga ^a   Leibovitz, Eugene ^a   Dagan, Ron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute otitis media; Clones; Multidrug resistance; Serotype 6A; Streptococcus pneumoniae

Indexed keywords

ERYTHROMYCIN; PENICILLIN G;

ACUTE OTITIS MEDIA; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHILD; CLONE; HUMAN; ISRAEL; JEW; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; MYRINGOTOMY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; WCIN GENE;

EID: 75949101919     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181b78e6e     Document Type: Article

References (22)

1. Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006;368:1495-1502.
2. Farrell DJ, Klugman KP, Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J. 2007;26:123-128.
3. Jacobs MR, Good CE, Bajaksouzian S, et al. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis. 2008;47:1388-1395.
4. Hanage WP, Huang SS, Lipsitch M, et al. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis. 2007;195:347-352.
5. Reinert RR, Jacobs MR, Appelbaum PC, et al. Relationship between the original multiply Resistant South African isolates of Streptococcus pneu-moniae from 1977 to 1978 and contemporary international resistant clones. J Clin Microbiol. 2005;43:6035-6041.
6. Choi EH, Kim SH, Eun BW, et al. Streptococcus pneumoniae Serotype 19A in Children, South Korea. Emerg Infect Dis. 2008;14:275-281.
7. Dagan R, Givon-Lavi N, Leibovitz E, et al. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis. 2009;199:776-785.
8. Statistical Yearbook of the Negev Bedouin. Beer-Sheva, Israel: Ben-Gurion University of the Negev; 2004.
9. Levy A, Fraser D, Vardi H, et al. Hospitalizations for infectious diseases in Jewish and Bedouin children in southern Israel. Eur J Epidemiol. 1998;14: 179-186.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement. Wayne PA: Clinical and Laboratory Institute; 2008. Document M100-S18.
11. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 1976;43:699-705.
12. Park IH, Park S, Hollingshead SK, et al. Genetic basis for the new pneumococcal serotype, 6C. Infect Immun. 2007;75:4482-4489.
13. Porat N, Barkai G, Jacobs MR, et al. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine sero-types causing acute otitis media in southern Israel, including two new serotypes. J Infect Dis. 2004;189:385-392.
14. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology. 1998;144:3049-3060.
15. Huang SS, Platt R, Rifas-Shiman SL, et al. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005;116:e408-e413.
16. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298:1772-1778.
17. Lipsitch M, O'Neill K, Cordy D, et al. Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine. J Infect Dis. 2007;196:1221-1227.
18. Moore MR, Gertz RE Jr, Woodbury RL, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis. 2008;197:1016-1027.
19. Pai R, Moore MR, Pilishvili T, et al. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis. 2005;192:1988-1995.
20. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409. (Pubitemid 32128672)
21. Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis. 2002;185:927-936.
22. Mbelle N, Huebner RE, Wasas AD, et al. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 1999;180:1171-1176.